• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型不对称工程化 Fc 变体的晶体结构,其对 FcγRs 的亲和力得到改善。

Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.

机构信息

Research Division, Chugai Pharmaceutical Co., Ltd., Japan.

Research Division, Chugai Pharmaceutical Co., Ltd., Japan.

出版信息

Mol Immunol. 2014 Mar;58(1):132-8. doi: 10.1016/j.molimm.2013.11.017. Epub 2013 Dec 14.

DOI:10.1016/j.molimm.2013.11.017
PMID:24334029
Abstract

Enhancing the effector function by optimizing the interaction between Fc and Fcγ receptor (FcγR) is a promising approach to enhance the potency of anticancer monoclonal antibodies (mAbs). To date, a variety of Fc engineering approaches to modulate the interaction have been reported, such as afucosylation in the heavy chain Fc region or symmetrically introducing amino acid substitutions into the region, and there is still room to improve FcγR binding and thermal stability of the CH2 domain with these approaches. Recently, we have reported that asymmetric Fc engineering, which introduces different substitutions into each Fc region of heavy chain, can further improve the FcγR binding while maintaining the thermal stability of the CH2 domain by fine-tuning the asymmetric interface between the Fc domain and FcγR. However, the structural mechanism by which the asymmetrically engineered Fc improved FcγR binding remained unclear. In order to elucidate the mechanism, we solved the crystal structure of a novel asymmetrically engineered Fc, asym-mAb23, in complex with FcγRIIIa. Asym-mAb23 has enhanced binding affinity for both FcγRIIIa and FcγRIIa at the highest level of previously reported Fc variants. The structural analysis reveals the features of the asymmetrically engineered Fc in comparison with symmetric Fc and how each asymmetrically introduced substitution contributes to the improved interaction between asym-mAb23 and FcγRIIIa. This crystal structure could be utilized to enable us to design a more potent asymmetric Fc.

摘要

通过优化 Fc 与 Fcγ 受体 (FcγR) 之间的相互作用来增强效应功能是提高抗癌单克隆抗体 (mAb) 效力的一种有前途的方法。迄今为止,已经报道了多种 Fc 工程改造方法来调节相互作用,例如在重链 Fc 区域中去岩藻糖基化或在该区域中对称引入氨基酸取代,并且这些方法仍然有改进 FcγR 结合和 CH2 结构域热稳定性的空间。最近,我们报道了不对称 Fc 工程改造,它在重链的每个 Fc 区域中引入不同的取代,可以通过微调 Fc 结构域和 FcγR 之间的不对称界面,进一步提高 FcγR 结合,同时保持 CH2 结构域的热稳定性。然而,不对称工程化 Fc 提高 FcγR 结合的结构机制仍不清楚。为了阐明该机制,我们解析了新型不对称工程化 Fc,asym-mAb23 与 FcγRIIIa 复合物的晶体结构。asym-mAb23 与 FcγRIIIa 和 FcγRIIa 的结合亲和力均高于之前报道的 Fc 变体的最高水平。结构分析揭示了不对称工程化 Fc 与对称 Fc 的区别,以及每个不对称引入的取代如何有助于改善 asym-mAb23 与 FcγRIIIa 之间的相互作用。该晶体结构可用于帮助我们设计更有效的不对称 Fc。

相似文献

1
Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.一种新型不对称工程化 Fc 变体的晶体结构,其对 FcγRs 的亲和力得到改善。
Mol Immunol. 2014 Mar;58(1):132-8. doi: 10.1016/j.molimm.2013.11.017. Epub 2013 Dec 14.
2
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.一种 IgG 的工程化 Fc 变体通过结构干扰消除了所有免疫效应功能。
Methods. 2014 Jan 1;65(1):114-26. doi: 10.1016/j.ymeth.2013.06.035. Epub 2013 Jul 17.
3
Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant.与去岩藻糖基化 Fc 变体相比,新型非对称工程化抗体 Fc 变体具有更高的 FcγR 结合亲和力和特异性。
MAbs. 2013 Mar-Apr;5(2):229-36. doi: 10.4161/mabs.23452. Epub 2013 Feb 13.
4
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.人源单克隆IgG糖变体的多角度效应功能分析
PLoS One. 2015 Dec 11;10(12):e0143520. doi: 10.1371/journal.pone.0143520. eCollection 2015.
5
Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies.不对称 Fc 工程极大地增强了抗体依赖的细胞毒性 (ADCC) 效应功能和修饰抗体的稳定性。
J Biol Chem. 2014 Feb 7;289(6):3571-90. doi: 10.1074/jbc.M113.513366. Epub 2013 Dec 5.
6
Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.与激活型Fc受体FcγRIIIa结合的GASDALIE Fc的结构表征
J Struct Biol. 2016 Apr;194(1):78-89. doi: 10.1016/j.jsb.2016.02.001. Epub 2016 Feb 2.
7
An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages.一种工程化的人 Fc 变体,对 FcγRIIIa 具有极高的选择性,揭示了 FcγRIIIa 的交联介导了 GM-CSF 分化的巨噬细胞的强大抗体依赖的细胞吞噬作用。
Front Immunol. 2019 Mar 27;10:562. doi: 10.3389/fimmu.2019.00562. eCollection 2019.
8
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.治疗性抗体的Fc优化可增强其体外杀伤肿瘤细胞的能力,并通过低亲和力激活型Fcγ受体在体内控制肿瘤生长。
Cancer Res. 2007 Sep 15;67(18):8882-90. doi: 10.1158/0008-5472.CAN-07-0696.
9
Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.Fc 蛋白和 Fc 糖基工程联合修饰 scFv-Fc 融合蛋白可协同增强 CD16a 结合,但不能进一步增强 NK 细胞介导的 ADCC。
J Immunol Methods. 2011 Oct 28;373(1-2):67-78. doi: 10.1016/j.jim.2011.08.003. Epub 2011 Aug 9.
10
Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.具有多聚化Fc结构域的抗CD20抗体:一种清除B细胞并增强自身免疫性疾病治疗效果的新策略。
J Immunol. 2016 Feb 1;196(3):1165-76. doi: 10.4049/jimmunol.1501755. Epub 2015 Dec 22.

引用本文的文献

1
Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation.系统制备具有对称和非对称均一聚糖的 66- IgG 文库及其功能评价。
J Am Chem Soc. 2024 Aug 21;146(33):23426-23436. doi: 10.1021/jacs.4c06558. Epub 2024 Aug 6.
2
The effect of Fc region affinity of protein-based antibody-recruiting molecules on antibody-dependent cellular cytotoxicity.基于蛋白质的抗体招募分子的Fc区域亲和力对抗体依赖性细胞毒性的影响。
RSC Adv. 2024 Jul 22;14(32):22860-22866. doi: 10.1039/d4ra03391d. eCollection 2024 Jul 19.
3
Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement.
一种抗登革热/寨卡病毒抗体通过损害Fcγ受体结合来激活补体,具有强大的效力并消除了抗体依赖增强作用的风险。
Antibodies (Basel). 2023 May 15;12(2):36. doi: 10.3390/antib12020036.
4
The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa.免疫球蛋白 G 的 Fab 部分在 CL 结构域中具有与 Fcγ受体 IIIa 相互作用的位点。
MAbs. 2022 Jan-Dec;14(1):2038531. doi: 10.1080/19420862.2022.2038531.
5
Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC.FcγRIIIA/FcγRIV对去岩藻糖基化IgG的跨物种更高敏感性以增强抗体依赖的细胞介导的细胞毒性作用
Antib Ther. 2021 Aug 19;4(3):159-170. doi: 10.1093/abt/tbab016. eCollection 2021 Jul.
6
Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding.鉴定 IgG1 Fc 天冬酰胺 325 的脱酰胺作用及其对抗体依赖的细胞介导的细胞毒性和 FcγRIIIa 结合的影响。
Sci Rep. 2020 Jan 15;10(1):383. doi: 10.1038/s41598-019-57184-2.
7
Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function.用于降低效应功能的双特异性抗体的不对称Fc工程
Antibodies (Basel). 2017 May 16;6(2):7. doi: 10.3390/antib6020007.
8
Recombinant Proteins and Monoclonal Antibodies.重组蛋白与单克隆抗体。
Adv Biochem Eng Biotechnol. 2021;175:281-318. doi: 10.1007/10_2017_32.
9
Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.鉴定具有增强的FcRn结合能力且与类风湿因子自身抗体结合未增加的人IgG1变体。
MAbs. 2017 Jul;9(5):844-853. doi: 10.1080/19420862.2017.1314873. Epub 2017 Apr 7.
10
Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins.免疫球蛋白Fc异二聚体平台技术:从设计到在治疗性抗体和蛋白质中的应用
Front Immunol. 2016 Oct 6;7:394. doi: 10.3389/fimmu.2016.00394. eCollection 2016.